Oral squamous cell carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntarily participate and sign the informed consent; 2. Aged > 18 years and< 70 years; 3. Those who are highly suspected of oral cancer in combination with medical history, imaging and other related examinations, who have been diagnosed with oral cancer in the past and are suspected of recurrence after complete remission of oral cancer treatment, who can obtain the results of medical examination and plan surgery; 4. Willing and able to follow schedule visits, treatment plans and laboratory tests; 5. The general biochemical tests (heart, liver, kidney, blood routine) and other indicators in the clinical laboratory were all within the normal range or abnormal without clinical significance.
Exclusion criteria
Exclusion criteria: 1. Patients who plan to become pregnant within 6 months, or are pregnant or breastfeeding; 2. Those who are allergic to experimental drugs, allergic constitution or allergic to multiple drugs; 3. Those who are in poor general condition and whose heart, lung, liver, kidney and other important organ functions cannot tolerate surgery; 4. Before the injection of 18F-FDG, the fasting blood glucose level exceeds 11.0 mmol/L; 5. Weight over 100 kg; 6. Patients with claustrophobia; 7. Those who cannot tolerate lying down for 15-30 minutes; 8. The researchers believe that it is not suitable to participate in this clinical trial; 9. Those who have participated in clinical trials or are participating in other clinical trials within the past month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| rang of primary lesions;number of metastatic lesions; | — |
Countries
China
Contacts
Zhongnan Hospital of Wuhan University